Low omentin-1 levels are related with clinical and metabolic parameters in obese children

Experimental and Clinical Endocrinology and Diabetes

Volumn 121, Issue 10, 2013, Pages 595-600

  Catli, G ^a   Anik, A ^a   Abaci, A ^a   Kume, T ^a   Bober, E ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

childhood; insulin resistance; obesity; omentin 1

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMENTIN 1; UNCLASSIFIED DRUG;

ARM CIRCUMFERENCE; ARTICLE; BODY HEIGHT; BODY MASS; CHILD; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; METABOLIC DISORDER; METABOLIC PARAMETERS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SCHOOL CHILD; SKINFOLD; SYSTOLIC BLOOD PRESSURE; THYROID FUNCTION TEST; WAIST CIRCUMFERENCE; WEIGHT GAIN;

ADOLESCENT; BLOOD PRESSURE; BODY MASS INDEX; CHILD; CYTOKINES; FEMALE; GPI-LINKED PROTEINS; HUMANS; INSULIN RESISTANCE; LECTINS; MALE; OBESITY; WAIST CIRCUMFERENCE;

EID: 84889096783     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0033-1355338     Document Type: Article

References (31)

1. Huang J. S., Barlow S. E., Quiros-Tejeira R. E. et al. The NASPGHAN Obesity Task Force. Consensus Statement: Childhood Obesity for Pediatric Gastroenterologists. J Pediatr Gastroenterol Nutr: 2012; 56 99 109
2. Despres J. P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature: 2006; 444 881 887 (Pubitemid 46024995)
3. Lago F., Gomez R., Gomez-Reino J. J. et al. Adipokines as novel modulators of lipid metabolism. Trends Biochem Sci: 2009; 34 500 510
4. Van Harmelen V., Reynisdottir S., Eriksson P. et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes: 1998; 47 913 917 (Pubitemid 28255665)
5. Whitehead J. P., Richards A. A., Hickman I. J. et al. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab: 2006; 8 264 280
6. Trayhurn P., Wood I. S. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans: 2005; 33 1078 1081 (Pubitemid 41659117)
7. Wang Y., Lam K. S., Kraegen E. W. et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem: 2007; 53 34 41 (Pubitemid 46047761)
8. Krusinova E., Pelikanova T. Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis? Diabetes Res Clin Pract: 2008; 82 S127 S134
9. Alessi M. C., Peiretti F., Morange P. et al. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes: 1997; 46 860 867 (Pubitemid 27188265)
10. Fried S. K., Bunkin D. A., Greenberg A. S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab: 1998; 83 847 850 (Pubitemid 28496456)
11. Auguet T., Quintero Y., Riesco D. et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet: 2011; 12 60
12. Ramanjaneya M., Chen J., Brown J. E. et al. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology: 2010; 151 3169 3180
13. Komiya T., Tanigawa Y., Hirohashi S. Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. Biochem Biophys Res Commun: 1998; 251 759 762 (Pubitemid 28512784)
14. Yang R. Z., Lee M. J., Hu H. et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab: 2006; 290 E1253 E1261 (Pubitemid 43847911)
15. de Souza Batista C. M., Yang R. Z., Lee M. J. et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes: 2007; 56 1655 1661 (Pubitemid 46842600)
16. Elbein S. C., Hoffman M. D., Teng K. et al. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes: 1999; 48 1175 1182 (Pubitemid 29226368)
17. Hanson R. L., Ehm M. G., Pettitt D. J. et al. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet: 1998; 63 1130 1138 (Pubitemid 30418584)
18. Vionnet N., Hani E. H., Dupont S. et al. Genome wide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet: 2000; 67 1470 1480
19. Wiltshire S., Hattersley A. T., Hitman G. A. et al. A genome wide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet: 2001; 69 553 569 (Pubitemid 32777694)
20. Prats-Puig A., Bassols J., Bargalló E. et al. Toward an early marker of metabolic dysfunction: omentin-1 in prepubertal children. Obesity (Silver Spring): 2011; 19 1905 1907
21. Kuczmarski R. J., Ogden C. L., Guo S. S. et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11: 2002; 246 1 190
22. Tanner J. M., Whitehouse R. H. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child: 1976; 51 170 179
23. American Academy of Pediatrics National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics: 1992; 89 525 584
24. Genuth S., Alberti K. G., Bennett P. et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care: 2003; 26 3160 3167
25. Valerio G., Licenziati M. R., Iannuzzi A. et al. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis: 2006; 16 279 284 (Pubitemid 43983096)
26. Rosner B., Prineas R. J., Loggie J. M. et al. Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United States. J Pediatr: 1993; 123 871 886 (Pubitemid 23353249)
27. Shibata R., Ouchi N., Takahashi R. et al. Omentin as a novel biomarker of metabolic risk factors. Diabetol Metab Syndr: 2012; 4 37
28. Ouchi N., Parker J. L., Lugus J. J. et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol: 2011; 11 85 97
29. El-Mesallamy H. O., El-Derany M. O., Hamdy N. M. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med: 2011; 28 1194 1200
30. Tan B. K., Adya R., Farhatullah S. et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes: 2008; 57 801 880
31. Moreno-Navarrete J. M., Catalán V., Ortega F. et al. Circulating omentin concentration increases after weight loss. Nutr Metab (Lond): 2010; 9 7 27